What is BioInformatics?
BioInformatics Inc. operates as a critical provider of market intelligence, focusing on key sectors such as life sciences, analytical instruments, and clinical diagnostics. The company excels in delivering both quantitative and qualitative market research, alongside bespoke consulting services. By cultivating an extensive network of over 55,000 scientists and biomedical researchers, BioInformatics offers unparalleled insights designed to foster business expansion and keep clients competitive in the dynamic life sciences landscape. Their offerings include comprehensive market research reports and informative newsletters.
How much funding has BioInformatics raised?
BioInformatics has raised a total of $21M across 1 funding round:
Series B
$21M
Series B (2018): $21M, investors not publicly disclosed
What's next for BioInformatics?
The recent major strategic investment suggests BioInformatics is poised for significant scaling and expansion of its intelligence-gathering capabilities. This capital infusion is likely to be directed towards enhancing its data analytics platforms, broadening its research network, and potentially exploring new market segments within the broader healthcare and technology industries. The company's focus on enterprise-level clients indicates a strategy geared towards solidifying its position as a leader in specialized market intelligence.
See full BioInformatics company page
